Clinical Research Directory
Browse clinical research sites, groups, and studies.
DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma
Sponsor: Barnet Dulaney Perkins Eye Centers
Summary
DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.
Official title: How Does First Line Treatment With DSLT Perform in Treatment-naïve Patients With Newly Diagnosed Primary Open Angle Glaucoma
Key Details
Gender
All
Age Range
30 Years - Any
Study Type
OBSERVATIONAL
Enrollment
55
Start Date
2025-03-31
Completion Date
2027-12-31
Last Updated
2025-04-18
Healthy Volunteers
No
Conditions
Interventions
DSLT enables newly diagnosed patients to remain well controlled and off medications
DSLT enables newly diagnosed patients to remain well controlled and off medications
Locations (1)
Barnet Dulaney Perkins Eye Centers
Mesa, Arizona, United States